Delivery Order W81XWH18D0027-W81XWH18F0124

Award Date 5/2/18
Potential Completion Date 5/1/19
Potential Value $82K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ann Arbor, MI 48108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $24,623.65. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to support the recurring pharmaceutical and medical supply needs of military health facilities worldwide. The contract covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $78,006.06 for pharmaceutical products and medical supplies. The award was made by the Defense Logistics Agency (DLA), a defense agency, under the SPE2DB indefinite delivery contract (IDC) program, which has a total potential value of $499,999,999 and is valid through November 2026. The contract covers a comprehensive range of pharmaceutical items, including branded and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order contract with a ceiling value of $11,449.78. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide. The contract is part of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $1,278.20. The contract was awarded by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities nationwide. The contract is part of a larger indefinite...
This is a $4,311.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB program with DLA, valued up to $4,999,999 through 2025. This single-award vehicle enables DLA to place orders for a broad range of pharmaceutical products, including...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The award, with a ceiling value of $26,681.01, is for the delivery of various pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities globally. The contract has a firm fixed-price delivery order and runs through April 16, 2024. This award...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $8,339.18. It was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract covers the delivery of various medications, including...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order worth $1,492.79. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract covers the delivery of various pharmaceutical items, including medications like flumazenil injections,...

This is a federal contract award by the Defense Health Agency (DHA), a defense agency, to Aapharmasyn LLC, a small disadvantaged woman-owned limited liability company. The contract, valued at $82,000.00, is for experimental therapeutics medicinal chemistry services. The contract is a delivery order awarded under the Experimental Therapeutics Medicinal Chemistry master IDIQ contract vehicle. The contract has no set-aside designation. The period of performance for this contract runs through May 1, 2019.

Generated 4/2/25, 5:53 PM